Factors that impact choice of antidepressant treatment in medically complex patients.
In medically complex patients with multiple comorbid illnesses who require concomitant medications, selecting the optimal antidepressant (ie, low risk of adverse effects and/or pharmacokinetic interactions) for an individual patient is critical for positive long-term patient outcomes. The serotonin-...
| Publicado en: | CNS Spectrums: The International Journal of Neuropsychiatric Medicine Vol. 14; pp. 20 - 28 |
|---|---|
| Autores principales: | , |
| Formato: | case study Journal Article |
| Publicado: |
Cambridge University Press
Dec2009 Supplement
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105177579&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 105177579 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10928529 1XG0 jtl: CNS Spectrums: The International Journal of Neuropsychiatric Medicine issn: 10928529 maglogo: N pubinfo: dt: Dec2009 Supplement vid: 14 pid: 15979 pub: Cambridge University Press artinfo: ui: 105177579 105177579 NLM20397588 2010629669 10.1017/s1092852900026377 NLM20397588 105177579 ppf: 20 ppct: 8 formats: tig: atl: Factors that impact choice of antidepressant treatment in medically complex patients. aug: au: Dago PL Dago, Pedro Luis affil: Department of Psychiatry and Behavioral Sciences, Feinberg School of Medicine of Northwestern University, 446 East Ontario Avenue, Chicago, IL 60611-3008, USA sug: subj: Antidepressive Agents Therapeutic Use Depression Drug Therapy Serotonin Uptake Inhibitors Therapeutic Use Adult Antidepressive Agents Adverse Effects Antidepressive Agents Pharmacokinetics Cardiovascular Diseases Chemically Induced Decision Making Kidney Diseases Chemically Induced Liver Diseases Etiology Male Serotonin Uptake Inhibitors Adverse Effects Serotonin Uptake Inhibitors Pharmacokinetics Treatment Outcomes Adult: 19-44 years Male ab: In medically complex patients with multiple comorbid illnesses who require concomitant medications, selecting the optimal antidepressant (ie, low risk of adverse effects and/or pharmacokinetic interactions) for an individual patient is critical for positive long-term patient outcomes. The serotonin-norepinephrine reuptake inhibitors (SNRls) are increasingly being used as first-line treatment for major depressive disorder (MDD) and may prove beneficial for treatment of medically complex patients.Thus, it is key for clinicians to evaluate the differences in the pharmacokinetic and tolerability profiles of the SNRI class of antidepressants, evaluating differences both within the class and compared with other antidepressants used to treat MDD. pubtype: Academic Journal doctype: case study Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|